Us Congress 2023-2024 Regular Session

Us Congress House Bill HB9540

Introduced
9/11/24  

Caption

Fight Illicit Pill Presses Act of 2024

Impact

If enacted, HB 9540 would have significant implications for manufacturers and distributors of tableting and encapsulating machines within the United States. The bill requires the Attorney General to implement regulations within 180 days of its enactment, which will stipulate the detailed requirements for compliance. The introduction of a mandatory serial number system is expected to increase the difficulty of operating unregulated or illicit enterprises, thereby aiding law enforcement in tracking and apprehending those involved in the illegal drug trade. This could lead to a decrease in the availability of counterfeit pills and other harmful substances that have contributed to the opioid crisis.

Summary

House Bill 9540, known as the 'Fight Illicit Pill Presses Act of 2024', proposes amendments to the Controlled Substances Act aimed at strengthening regulations around the manufacturing and distribution of tableting and encapsulating machines. Specifically, the bill mandates that these machines must be identified by serial numbers that are permanently affixed. This measure is designed to enhance traceability and accountability in the production of controlled substances, thereby aiding in the fight against illicit drug trafficking and ensuring that the machines used in the creation of such substances are properly monitored.

Contention

While HB 9540 is generally supported due to its focus on regulation and safety, some stakeholders may raise concerns regarding the burden it places on manufacturers. Industry advocates may argue that these requirements could lead to increased operational costs and logistical challenges. Furthermore, there may be discussions about the effectiveness of such measures in truly curbing illicit drug manufacturing, raising the question of whether enforcement mechanisms will be adequately funded and prioritized. Overall, the bill represents a legislative effort to combat a pressing public health crisis but does not come without potential pushback from segments of the manufacturing industry.

Companion Bills

US SB4984

Related Fight Illicit Pill Presses Act

Similar Bills

No similar bills found.